Table 1.
Patient demographics, ocular co-morbidities (excluding multiple failed corneal grafts), underlying diagnosis, year surgery was performed and number of previous grafts (n = 39)
| Number (%) | |
|---|---|
| Demographics | |
| Mean age (range) | 56.9 (24.8–88.4) |
| Male gender (number, %) | 24 (62%) |
| Mean duration of follow up in months (SD) | 28.4 (12.9) |
| Mean LogMAR vision in operated eye (SD) | 2.22 (0.36) |
| Mean LogMAR vision in fellow eye (SD) | 1.81 (1.18) |
| Number of patients with NPL vision in fellow eye (%) | 15 (38.5%) |
| Ocular co-morbidities | |
| None | 10 (26%) |
| Glaucoma | 24 (62%) |
| No previous glaucoma surgery | 6 (15%) |
| Previous trabeculectomy | 3 (8%) |
| Previous tube shunt | 15 (38%) |
| Limbal stem cell deficiency | 10 (26%) |
| Retinal detachments | 7 (18%) |
| Low visual potential (aniridia, congenital cataracts, nanophthalmos) | 7 (18%) |
| Chronic uveitis | 3 (8%) |
| HSV | 1 (3%) |
| Underlying diagnosis | |
| Pseudophakic/aphakic bullous keratopathy (multiple intraocular surgeries) | 22 (56%) |
| Limbal stem cell failure | 6 (15%) |
| Ectasia (keratoconus, Ehlers Danlos syndrome) | 4 (10%) |
| Congenital anterior segment dysgenesis (Riegers, nanophthalmos, microphthalmos) | 4 (10%) |
| Aniridia | 3 (8%) |
| Year keratoprosthesis surgery was performed | |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 11 |
| 2014 | 15 |
| 2015 | 5 |
| Previous graft surgery | |
| 0 | 2 (5%) |
| 1 | 6 (15%) |
| 2 | 11 (28%) |
| 3 | 10 (26%) |
| 4 | 4 (10%) |
| 5 | 1 (3%) |
| 6 | 2 (5%) |
| 7 | 2 (5%) |
| 8 | 1 (3%) |